These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6880719)

  • 1. Digoxin therapy and left ventricular performance in premature infants with patent ductus arteriosus.
    Lundell BP; Boréus LO
    Acta Paediatr Scand; 1983 May; 72(3):339-43. PubMed ID: 6880719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular systolic time intervals in preterm infants with patent ductus arteriosus.
    Lundell BP; Wallgren CG
    Acta Paediatr Scand; 1983 Jan; 72(1):105-10. PubMed ID: 6858671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1000 g.
    McNamara PJ; Stewart L; Shivananda SP; Stephens D; Sehgal A
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):150-7. PubMed ID: 20363478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin therapy in low-birth-weight infants with patent ductus arteriosus.
    Berman W; Dubynsky O; Whitman V; Friedman Z; Maisels MJ
    J Pediatr; 1978 Oct; 93(4):652-5. PubMed ID: 702246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of systolic time intervals in the diagnosis of large patent ductus arteriosus in fluid-restricted and mechanically ventilated preterm infants.
    Heitz F; Fouron JC; van Doesburg NH; Bard H; Teasdale F; Chessex P; Davignon A
    Pediatrics; 1984 Dec; 74(6):1069-74. PubMed ID: 6504626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin and indomethacin in preterm infants with PDA.
    Zarfin Y; Koren G; Perlman M
    J Pediatr; 1984 Oct; 105(4):678-9. PubMed ID: 6481555
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of ligation of patent ductus arteriosus on left ventricular performance and its determinants in premature neonates.
    Kimball TR; Ralston MA; Khoury P; Crump RG; Cho FS; Reuter JH
    J Am Coll Cardiol; 1996 Jan; 27(1):193-7. PubMed ID: 8522694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiography as a guide for patent ductus arteriosus ibuprofen treatment and efficacy prediction.
    Desandes R; Jellimann JM; Rouabah M; Haddad F; Desandes E; Boubred F; Semama DS; Vieux R; Hascoët JM
    Pediatr Crit Care Med; 2012 May; 13(3):324-7. PubMed ID: 21760564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of mefenamic acid in preterm infants with patent ductus arteriosus.
    Ito K; Niida Y; Sato J; Owada E; Ito K; Umetsu M
    Acta Paediatr Jpn; 1994 Aug; 36(4):387-91. PubMed ID: 7942001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and echocardiographic effects of digoxin in low birth weight infants with left-to-right shunting due to patent ductus arteriosus.
    Warburton D; Bell EF; Oh W
    Dev Pharmacol Ther; 1980; 1(2-3):189-200. PubMed ID: 6927548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The problem of ductal patency in prematures.
    O'Loughlin JE
    Pediatr Ann; 1981 Apr; 10(4):39-46. PubMed ID: 7015261
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of patent ductus arteriosus in preterm infants].
    Jaso E; Tejedor JC; Quero J; Pérez Rodríguez J; Agustí B; Castro J; García Frías E
    An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic Effects on Systemic Blood Flow and Ductal Shunting Flow after Loading Dose of Intravenous Caffeine in Preterm Infants according to the Patency of Ductus Arteriosus.
    Hwang J; Kim YS; Shin JH; Choi BM
    J Korean Med Sci; 2018 Jan; 33(4):e25. PubMed ID: 29318792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications associated with digoxin therapy in low-birth weight infants.
    Johnson GL; Desai NS; Pauly TH; Cunningham MD
    Pediatrics; 1982 Apr; 69(4):463-5. PubMed ID: 7070893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of indomethacin on digoxin pharmacokinetics in preterm infants.
    Koren G; Zarfin Y; Perlman M; MacLeod SM
    Pediatr Pharmacol (New York); 1984; 4(1):25-30. PubMed ID: 6739184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical management of small preterm infants with symptomatic patent ductus arteriosus.
    Cotton RB; Stahlman MT; Kovar I; Catterton WZ
    J Pediatr; 1978 Mar; 92(3):467-73. PubMed ID: 632994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dopplersonographic findings in neonates with significant persistent ductus arteriosus].
    Robel-Tillig E; Knüpfer M; Pulzer F; Vogtmann C
    Z Geburtshilfe Neonatol; 2002 Apr; 206(2):51-6. PubMed ID: 12015635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.